Editorial
doi: 10.1016/j.jacc.2019.05.009.
Oral Anticoagulants in Liver Disease: Not Child's Play
Affiliations
- PMID: 31248552
- DOI: 10.1016/j.jacc.2019.05.009
Item in Clipboard
Editorial
Oral Anticoagulants in Liver Disease: Not Child's Play
J Am Coll Cardiol.
.
Free article
No abstract available
Keywords: atrial fibrillation; cirrhosis; direct oral anticoagulant; liver disease; non-vitamin K oral antagonist; warfarin.
Comment on
-
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease.J Am Coll Cardiol. 2019 Jul 2;73(25):3295-3308. doi: 10.1016/j.jacc.2019.04.052. J Am Coll Cardiol. 2019. PMID: 31248551
Similar articles
-
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29. Int J Stroke. 2016. PMID: 26927811
-
Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.Am J Med. 2015 Sep;128(9):1007-14.e2. doi: 10.1016/j.amjmed.2015.03.034. Epub 2015 Apr 22. Am J Med. 2015. PMID: 25910790 Clinical Trial.
-
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.BMJ. 2017 Feb 10;356:j510. doi: 10.1136/bmj.j510. BMJ. 2017. PMID: 28188243 Free PMC article.
-
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants.Clin Interv Aging. 2015 Sep 3;10:1431-44. doi: 10.2147/CIA.S80641. eCollection 2015. Clin Interv Aging. 2015. PMID: 26366064 Free PMC article. Review.
-
Use of oral anticoagulants in complex clinical situations with atrial fibrillation.Med Clin (Barc). 2018 Jun;150 Suppl 1:8-24. doi: 10.1016/S0025-7753(18)30666-3. Med Clin (Barc). 2018. PMID: 30502871 Review. English, Spanish.
Cited by
-
Efficacy and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and liver disease: an updated systematic review and meta-analysis.Arch Med Sci Atheroscler Dis. 2025 May 30;10:e78-e88. doi: 10.5114/amsad/205549. eCollection 2025. Arch Med Sci Atheroscler Dis. 2025. PMID: 40620744 Free PMC article. Review.
-
Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review.Adv Ther. 2020 May;37(5):1910-1932. doi: 10.1007/s12325-020-01307-z. Epub 2020 Apr 13. Adv Ther. 2020. PMID: 32285340 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
